Skip to main content
HR 7539 118th Congress House Health

LOANS for Biomedical Research Act

Introduced: March 5, 2024 Introduced by: Fitzpatrick, Brian K. Republican · Pennsylvania See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2024
Referred to the Subcommittee on Health.
Mar 5, 2024
Referred to the House Committee on Energy and Commerce.
Mar 5, 2024
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Long-term Opportunities for Advancing New Studies for Biomedical Research Act or the LOANS for Biomedical Research Act

This bill requires the Department of the Treasury to establish the BioBonds Program to support loans for clinical trials for eligible drugs and medical devices for unmet medical needs.

Under the program, fiscal agents purchase loans (up to $25 million per recipient) and issue collateralized bonds that are sold to investors and that are guaranteed by Treasury. An eligible borrower under this program is one conducting (or seeking to conduct) research related to a drug or device that is (1) intended to meet an unmet medical need; and (2) under investigation in certain types of controlled clinical trials, including a trial to investigate the safety and effectiveness of the drug or device. 

The Government Accountability Office (GAO) and Treasury must report on the program; GAO must also study whether similar programs should be established for other biomedical research projects.

 

What's happening now March 8, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 8
All 8 Democratic 6 Republican 2
D
Schneider, Bradley Scott
Illinois · Aug 20, 2024
 D
Levin, Mike
California · Jul 26, 2024
 D
Boyle, Brendan F.
Pennsylvania · Jun 26, 2024
 D
Gottheimer, Josh
New Jersey · Jun 25, 2024
 R
Smith, Adrian
Nebraska · May 22, 2024
 D
Tokuda, Jill N.
Hawaii · May 6, 2024
 R
Sessions, Pete
Texas · Apr 18, 2024
 D
Bishop, Sanford D.
Georgia · Mar 5, 2024
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7539: LOANS for Biomedical Research Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-7539/
MLA
"H.R. 7539: LOANS for Biomedical Research Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-7539/.
Bluebook (legal)
H.R. 7539, 118th Cong. (2026), https://openamerica.io/bill/118-HR-7539/.
Markdown link
[H.R. 7539: LOANS for Biomedical Research Act](https://openamerica.io/bill/118-HR-7539/)
Report a problem